文献速递性腺与生殖内分泌肥胖与代谢综合征

青少年多囊卵巢综合征的诊断与治疗策略

Approach to the diagnosis and treatment of polycystic ovarian syndrome in adolescent patients.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本文针对青少年多囊卵巢综合征(PCOS)诊断困难的问题,指出需在具备高雄激素血症和月经不规则两方面明确且持续证据时才可确诊,仅有单一特征者应视为高危并纵向随访。管理以生活方式干预为基础,复方口服避孕药为月经不规则和高雄激素血症的一线治疗,二甲双胍为代谢合并症的一线治疗。

要点

  • 青少年PCOS确诊需高雄激素血症和月经不规则同时存在且持续。
  • 仅有单一特征者应视为PCOS高风险,需纵向随访以避免漏诊或过度诊断。
  • 复方口服避孕药为月经不规则和高雄激素血症一线治疗,二甲双胍为代谢合并症一线治疗。

核心结论

  • 青少年PCOS应在高雄激素血症和月经不规则均有明确且持续证据时确诊,单一特征者应纵向随访。
  • PCOS是涉及长期代谢风险和心理健康不良结局的慢性疾病,青少年期是早期风险分层和预防干预的关键窗口。

主要发现

  • 青春期生理变化与PCOS关键特征重叠,导致青少年期诊断尤为困难。
  • PCOS不仅涉及生殖功能障碍,还与长期代谢风险和不良心理健康结局相关。

关键数值与推荐

  • 确诊需高雄激素血症和月经不规则两方面均有明确且持续证据。
  • 仅有单一特征者视为PCOS风险增加,应纵向随访。
  • 复方口服避孕药为月经不规则和高雄激素血症的一线治疗。
  • 二甲双胍为代谢合并症的一线治疗。

临床怎么用

  • 对仅有单一特征的青少年应纵向随访,避免漏诊和过度诊断。
  • 需仔细排除可模仿PCOS的其他疾病。
  • 管理以生活方式干预为基础,药物治疗根据临床表现、代谢特征、禁忌证和患者偏好个体化。
  • 复方口服避孕药提供性健康和生殖健康咨询机会,包括避孕和性传播感染防护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age. Its diagnosis during adolescence is particularly challenging, as physiological pubertal changes overlap with key features of PCOS; nevertheless, this developmental stage often represents the earliest window for clinical manifestation. Accordingly, a definitive diagnosis should be established only in the presence of clear and persistent evidence of both hyperandrogenism and menstrual irregularity. Adolescents presenting with a single feature should be considered at increased risk for PCOS and followed longitudinally in order to minimize both underdiagnosis and overdiagnosis. Careful exclusion of alternative diagnoses is essential, as several conditions may mimic PCOS. Importantly, PCOS extends beyond reproductive dysfunction and constitutes a chronic condition associated with long-term metabolic risk and adverse mental health outcomes. This broader disease spectrum underscores adolescence as a critical period for early risk stratification and preventive interventions. Management should prioritize lifestyle modification as the foundation of therapy, with pharmacological treatment individualized according to clinical presentation, metabolic profile, contraindications, and patient preferences. Combined oral contraceptive pills remain the first-line therapy for menstrual irregularity and hyperandrogenism and provide an important opportunity for counseling on sexual and reproductive health, including pregnancy prevention and protection against sexually transmitted infections. Metformin is recommended as first-line therapy for metabolic comorbidities, mirroring its established role in adult populations. All these considerations highlight adolescence as an important stage for accurate diagnosis, comprehensive risk assessment, and timely intervention in PCOS, with potential implications for long-term reproductive, metabolic, and psychosocial health.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Machado IFR, Tinano FR, Latronico AC, et al. Approach to the diagnosis and treatment of polycystic ovarian syndrome in adolescent patients. J Clin Endocrinol Metab. 2026. PMID: 42105324. doi:10.1210/clinem/dgag198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。